GSKNYSELive delayed
$50.74
-0.02-0.04%
SourceCNBCAs ofJul 23, 2026, 8:10 PM
Delayed market data from CNBC. Not investment advice.
Key statistics
Delayed fundamentals for GSK · Finnhub.
- Market cap
- $76.53B
- P/E (TTM)
- 13.39
- EPS (TTM)
- $1.424
- Div. yield
- 3.66%
- 52-week range
- $1,361.00 – $2,282.00
- Volume
- —
- Avg volume
- 4.66M
Price history
OHLC candles for GSK · 3mo · 1day · Twelve Data · EMA / RSI
-14.26%periodDirect mentions, stories that impact this name, and related market themes — with Impact Analysis on each headline.
DirectHigh impactGlobalMostly neutralGoogle News
GSK Lands FDA Approval for Nuvalent-Acquired Jideytro for NSCLCGSK Lands FDA Approval for Nuvalent-Acquired Jideytro for NSCLC Yahoo FinanceBroad market headline — check whether risk appetite shifts.
Watch: GSK · FDA · NSCLC · .SPX
DirectHigh impactGoogle News
Will GSK's Specialty Medicines Boost Q2 Revenue Growth?DirectHigh impactGoogle News
GSK Enters Lung Cancer Therapy Market with FDA Approval of JideyDirectHigh impactGoogle News
Q1 2026 GSK plc Earnings Call TranscriptDirectHigh impactGoogle News
Earnings Preview: GSK to Report Financial Results Pre-market on July 28DirectHigh impactGoogle News
GSK (GSK) Q4 2024 earnings summaryDirectHigh impactGoogle News
GSK (GSK) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseDirectHigh impactGoogle News
By mid-2027, analysts expect £6,000 in GSK shares to be worth…